Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Sexual-minority cancer survivors have worse access to care and higher odds of poor quality of life

Access to Care Worse for Sexual-Minority Cancer Survivors

0
Sexual-minority women with access deficits have increased odds of poor physical, mental quality of life
Individuals with pediatric-onset inflammatory bowel disease have an increased risk for cancer and mortality

Higher Risk for Cancer, Mortality Seen With Pediatric-Onset IBD

0
Risk for cancer, mortality increased for patients with pediatric-onset ulcerative colitis, Crohn disease
Men and women with type 2 diabetes have an increased risk for overall cancer and some site-specific cancers

Risk for Cancer Increased in Men, Women With T2DM

0
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women
The American Cancer Society has set a goal of a 40 percent reduction in overall cancer mortality by 2035

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035

0
Goal based on decrease in overall cancer death rates at pace seen among college graduates
A publicly available model can identify patients with asymptomatic Waldenström macroglobulinemia at high risk for progression

Model Predicts Progression Risk for Rare Type of Lymphoma

0
Model can improve monitoring of patients with asymptomatic Waldenström macroglobulinemia
Cardio-oncology is an emerging discipline and subspecialty in response to the rapidly growing number of patients with comorbid cardiovascular disease and cancer and the complexity of these conditions

Cardio-Oncology Services Growing in Number and Demand

0
Need for subspecialists increased due to more cancer survivors, aging population
Prior authorization obstacles are delaying patient access to radiation oncology treatments

ASTRO: Prior Authorization Obstacles Delaying Treatment

0
Almost all radiation oncologists report their patients are delayed from receiving life-saving treatment

April 2019 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2019. This roundup includes...
Despite thousands of lawsuits from people claiming that the weed killer glyphosate caused their cancer

EPA Says Weed Killer in Roundup Is Safe

0
EPA states that glyphosate 'is not likely to be carcinogenic to humans'
Tagraxofusp appears effective for treating the rare aggressive hematologic cancer blastic plasmacytoid dendritic-cell neoplasm

Targeted Therapy Promising for Rare Hematologic Cancer

0
Tagraxofusp seems effective for treating blastic plasmacytoid dendritic-cell neoplasm